Follow Us

Eye Health Insights

A review published in January 2024 highlights that 196 million people globally are affected by age-related macular degeneration (AMD), and this number is projected to rise to 288 million by 2040.

It has also been observed by research, specifically post-COVID, that eye fatigue and macular degeneration is progressing at a faster pace due to increased screen time. If left unmanaged, digital eye strain (DES) can decrease work productivity, impair sleep and hinder overall quality of life.

It is important to improve the eye care, So that eyesight remains healthy and active later in life.

Xanthogreen®: Natural, Fast acting Specialty Lutein Esters

A randomized, placebo-controlled trial involving 128 healthy volunteers aged 18 to 50 was conducted over a 12-week supplementation period. The primary focus was to evaluate improvements in Macular Pigment Optical Density (MPOD) using flicker photometry. Secondary parameters of eye health, such as contrast sensitivity, dry eye symptoms, visual processing speed, and intraocular pressure, were also assessed.

The study included three active groups, each receiving a different super-critically extracted lutein ester formulation—Xanthogreen®, Xanthogreen® TOS, and Xanthogreen® ULTRA—at varying doses, alongside a placebo group.

Xanthogreen® showed : Significant improvement in MPOD levels

MPOD (Macular Pigment Optical Density) is a key measure of the density of this protective pigment at the center of the retina. By optimizing MPOD levels, you can enhance the macular pigment’s protective capacity, ensuring clearer vision and promoting long-term eye health.

p<0.0001 against placebo

p<0.0001 against Xanthogreen®  and Xanthogreen® ULTRA

Placebo

Xanthogreen®

Xanthogreen® TOS

Xanthogreen® ULTRA

p<0.0001 against placebo

p<0.0001 against Xanthogreen®  and Xanthogreen® ULTRA

Placebo

Xanthogreen®

Xanthogreen® TOS

Xanthogreen® ULTRA

p<0.0001 against placebo

p<0.0001 against Xanthogreen®  and Xanthogreen® ULTRA

Placebo

Xanthogreen®

Xanthogreen® TOS

Xanthogreen® ULTRA

Improvement in MPOD at 0.25°

p<0.0001 against placebo

p<0.0001 against Xanthogreen®  and Xanthogreen® ULTRA

Placebo

Xanthogreen®

Xanthogreen® TOS

Xanthogreen® ULTRA

Improvement in MPOD at 0.5°

p<0.0001 against placebo

p<0.0001 against Xanthogreen®  and Xanthogreen® ULTRA

Placebo

Xanthogreen®

Xanthogreen® TOS

Xanthogreen® ULTRA

Improvement in MPOD at 1°

p<0.0001 against placebo

p<0.0001 against Xanthogreen®  and Xanthogreen® ULTRA

Placebo

Xanthogreen®

Xanthogreen® TOS

Xanthogreen® ULTRA

+40.37%

with Xanthogreen® TOS

+30.85%

with Xanthogreen®

+28.56%

with Xanthogreen® ULTRA

Xanthogreen® showed: Significant improvement in eye contrast sensitivity

Contrast sensitivity is key to seeing the world in vivid detail, allowing you to distinguish objects from their backgrounds with remarkable precision.

Contrast Senstivity

p<0.0001 against placebo

p<0.0001 against placebo

Placebo

Xanthogreen®

Xanthogreen® TOS

Xanthogreen® ULTRA

+0%

with Xanthogreen® TOS

+0%

with Xanthogreen®

+0%

with Xanthogreen® ULTRA